vs

Side-by-side financial comparison of DouYu International Holdings Ltd (DOYU) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

DouYu International Holdings Ltd is the larger business by last-quarter revenue ($147.1M vs $83.1M, roughly 1.8× PROCEPT BioRobotics Corp).

DouYu International Holdings Ltd operates a leading live streaming platform centered on video game and esports content primarily in mainland China. It offers interactive live streams covering professional esports tournaments, casual gaming content, and variety entertainment, targeting young gaming enthusiasts as its core user base, with main revenue streams including virtual gifting, advertising, and paid memberships.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

DOYU vs PRCT — Head-to-Head

Bigger by revenue
DOYU
DOYU
1.8× larger
DOYU
$147.1M
$83.1M
PRCT

Income Statement — Q2 FY2025 vs Q1 FY2026

Metric
DOYU
DOYU
PRCT
PRCT
Revenue
$147.1M
$83.1M
Net Profit
$-31.6M
Gross Margin
13.5%
64.9%
Operating Margin
-4.1%
Net Margin
-38.1%
Revenue YoY
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOYU
DOYU
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$76.4M
Q3 25
$83.3M
Q2 25
$147.1M
$79.2M
Q1 25
$130.5M
$69.2M
Q4 24
$68.2M
Q3 24
$58.4M
Q2 24
$142.0M
$53.4M
Net Profit
DOYU
DOYU
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$-21.4M
Q2 25
$-19.6M
Q1 25
$-11.0M
$-24.7M
Q4 24
$-18.9M
Q3 24
$-21.0M
Q2 24
$-6.8M
$-25.6M
Gross Margin
DOYU
DOYU
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
13.5%
65.4%
Q1 25
12.0%
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
8.2%
59.0%
Operating Margin
DOYU
DOYU
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-40.6%
Q3 25
-27.8%
Q2 25
-28.0%
Q1 25
-2.8%
-39.7%
Q4 24
-28.9%
Q3 24
-38.4%
Q2 24
-11.6%
-50.3%
Net Margin
DOYU
DOYU
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
-25.7%
Q2 25
-24.7%
Q1 25
-8.4%
-35.8%
Q4 24
-27.6%
Q3 24
-35.9%
Q2 24
-4.8%
-48.0%
EPS (diluted)
DOYU
DOYU
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.54
Q3 25
$-0.38
Q2 25
$-0.35
Q1 25
$-0.45
Q4 24
$-0.34
Q3 24
$-0.40
Q2 24
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOYU
DOYU
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$214.4M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$279.9M
$347.7M
Total Assets
$448.1M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOYU
DOYU
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$214.4M
$302.7M
Q1 25
$35.2M
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$558.8M
$214.1M
Total Debt
DOYU
DOYU
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
DOYU
DOYU
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$365.9M
Q3 25
$380.3M
Q2 25
$279.9M
$385.8M
Q1 25
$37.4M
$389.2M
Q4 24
$402.2M
Q3 24
$241.2M
Q2 24
$895.6M
$251.8M
Total Assets
DOYU
DOYU
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$508.1M
Q3 25
$511.5M
Q2 25
$448.1M
$513.1M
Q1 25
$60.8M
$519.4M
Q4 24
$534.0M
Q3 24
$374.1M
Q2 24
$1.1B
$374.4M
Debt / Equity
DOYU
DOYU
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOYU
DOYU

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons